SARAH CLARK: Open Payments
NPI 1497272025 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 14 payments from 7 companies in 2025. Trend: 2023 $273 · 2024 $341 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $194 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| ABBVIE INC. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: INVEGA SUSTENNA, REXULTI, SPRAVATO, VRAYLAR, UZEDY, INGREZZA, Jornay PM.
Industry payments across UT — which companies pay providers there.
